ZA989010B - Monolithic system containing one or more drugs consisting of three layers with different release mechanisms - Google Patents

Monolithic system containing one or more drugs consisting of three layers with different release mechanisms

Info

Publication number
ZA989010B
ZA989010B ZA989010A ZA989010A ZA989010B ZA 989010 B ZA989010 B ZA 989010B ZA 989010 A ZA989010 A ZA 989010A ZA 989010 A ZA989010 A ZA 989010A ZA 989010 B ZA989010 B ZA 989010B
Authority
ZA
South Africa
Prior art keywords
layers
system containing
release mechanisms
different release
monolithic system
Prior art date
Application number
ZA989010A
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Daniela Acerbi
Rossella Musa
Ruggero Bettini
Giovanni Caponetti
Pier Luigi Catellani
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA989010B publication Critical patent/ZA989010B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
ZA989010A 1997-10-03 1998-10-02 Monolithic system containing one or more drugs consisting of three layers with different release mechanisms ZA989010B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI002254A IT1295271B1 (it) 1997-10-03 1997-10-03 Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato

Publications (1)

Publication Number Publication Date
ZA989010B true ZA989010B (en) 1999-04-12

Family

ID=11377984

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA989010A ZA989010B (en) 1997-10-03 1998-10-02 Monolithic system containing one or more drugs consisting of three layers with different release mechanisms

Country Status (14)

Country Link
EP (1) EP1019029B1 (cs)
AR (1) AR043070A1 (cs)
AT (1) ATE248590T1 (cs)
AU (1) AU9629198A (cs)
BR (1) BR9815248A (cs)
CZ (1) CZ298851B6 (cs)
DE (1) DE69817848T2 (cs)
ES (1) ES2205558T3 (cs)
HU (1) HU225692B1 (cs)
IT (1) IT1295271B1 (cs)
NO (1) NO20001709L (cs)
SK (1) SK284552B6 (cs)
WO (1) WO1999017745A1 (cs)
ZA (1) ZA989010B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696600B2 (en) 2001-11-13 2004-02-24 Teva Pharmaceutical Industries, Ltd. L-DOPA ethyl ester salts and uses thereof
US7094427B2 (en) 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
CA2613631A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Improved dosage forms for movement disorder treatment
EP1970055B1 (en) * 2005-12-29 2010-11-24 Osmotica Kereskedelmi És Szolgáltató Kft Multi-layered tablet with triple release combination
CN102202656A (zh) 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
JP5905872B2 (ja) * 2010-04-07 2016-04-20 ルピン・リミテッド タペンタドールの制御放出医薬組成物
EP2508174A1 (en) 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
ITMI20121263A1 (it) * 2012-07-19 2014-01-20 Recordati Ind Chimica E Farma Ceutica S P A Forma farmaceutica multistrato
CN105431144A (zh) 2013-06-05 2016-03-23 思康脑侒股份有限公司 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合
AU2014332024B2 (en) 2013-10-07 2019-09-26 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
US9808478B2 (en) * 2015-04-17 2017-11-07 Steven Loyd Control release of fat soluble antioxidants from an oral formulation and method
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
JP2024501235A (ja) 2020-12-22 2024-01-11 アムニール ファーマスーティカルズ エルエルシー レボドパ投薬レジメン
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
CN117599009A (zh) * 2023-11-10 2024-02-27 长沙晶易医药科技股份有限公司 一种卡左双多巴三层片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Also Published As

Publication number Publication date
DE69817848T2 (de) 2005-04-07
IT1295271B1 (it) 1999-05-04
NO20001709D0 (no) 2000-04-03
CZ298851B6 (cs) 2008-02-27
HUP0004015A2 (hu) 2001-08-28
NO20001709L (no) 2000-06-05
HU225692B1 (en) 2007-06-28
ITMI972254A1 (it) 1999-04-03
WO1999017745A1 (en) 1999-04-15
ES2205558T3 (es) 2004-05-01
EP1019029A1 (en) 2000-07-19
SK284552B6 (sk) 2005-06-02
CZ20001200A3 (cs) 2000-09-13
AR043070A1 (es) 2005-07-20
ATE248590T1 (de) 2003-09-15
DE69817848D1 (de) 2003-10-09
BR9815248A (pt) 2000-11-21
SK4822000A3 (en) 2000-09-12
AU9629198A (en) 1999-04-27
EP1019029B1 (en) 2003-09-03
HUP0004015A3 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
ZA989010B (en) Monolithic system containing one or more drugs consisting of three layers with different release mechanisms
GR3036291T3 (en) Tablet with controlled release of alfuzosine chlorydrate
GB9425034D0 (en) Emergency response system
GB9809907D0 (en) Emergency response system
AU4394393A (en) Emergency response system
PL340337A1 (en) Drugs
AU6526896A (en) Substituted aromatic compounds and their pharmaceutical use
DE69511105D1 (de) Mehrschichtiges verschlusssystem
NZ302881A (en) Tricyclic benzazepine (vaspressin antagonist) derivatives and medicaments containing them
HUP9904335A3 (en) Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
HUP9902342A3 (en) Nitrogenous tricyclic compounds and drugs comprising the same
GB9519094D0 (en) Granulated active with controlled release
AU1454599A (en) Compounds inhibiting cd4-gp120 interaction and uses thereof
GB9601186D0 (en) Administration of Drugs
HUP9901715A3 (en) Layered tablet for the controlled release of active substances
GB9509890D0 (en) Emergency system
GB9506844D0 (en) Pharmaceutical microencapsulation
AU6119398A (en) Phenylpropenone compounds and medicines containing the same
AU1247599A (en) Security and emergency alarm system
GB9213880D0 (en) Emergency release
IL129574A0 (en) Benzenesulfonamide derivatives and drugs containing the same
GB8809659D0 (en) System for immobilising persons
AU4209397A (en) System for the security and position control of persons via satellite
GB2342904B (en) Emergency evacuation system
TW309998U (en) Structure of drug case with reminding functions